Advanced Therapies Congress 2024
London, March 19 – 20, 2024
Exothera is going to be at Advanced Therapies in March 2024.
This conference presentation explores the forefront of viral vector manufacturing, with a primary focus on the crucial interplay between manufacturing platform development, critical decisions and compliance with Chemistry, Manufacturing, and Controls (CMC) regulations.
Title: Advancements in Viral Vector Manufacturing: Platform Development, Critical Starting Material Selection, and Insights into AAV and Adenovirus Production
Abstract: The talk explores the aspects of selecting optimal starting materials, including cell lines and plasmids, as they significantly impact the quality and yield of viral vectors. Special focus is placed on Adeno-Associated Virus (AAV) and Adenovirus, shedding light on their unique challenges and opportunities in the quest for efficient and scalable production processes. Attendees will gain valuable insights into the evolving landscape of viral vector manufacturing, addressing key considerations for optimizing production and advancing gene therapy and vaccine development.